loading
Aligos Therapeutics Inc stock is traded at $7.66, with a volume of 27,020. It is up +1.73% in the last 24 hours and down -23.93% over the past month. Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
See More
Previous Close:
$7.53
Open:
$7.38
24h Volume:
27,020
Relative Volume:
0.34
Market Cap:
$40.94M
Revenue:
$7.97M
Net Income/Loss:
$-75.74M
P/E Ratio:
-0.3154
EPS:
-24.2853
Net Cash Flow:
$-85.33M
1W Performance:
-17.81%
1M Performance:
-23.93%
6M Performance:
+36.79%
1Y Performance:
-19.20%
1-Day Range:
Value
$7.38
$7.72
1-Week Range:
Value
$7.38
$9.3813
52-Week Range:
Value
$3.76
$46.80

Aligos Therapeutics Inc Stock (ALGS) Company Profile

Name
Name
Aligos Therapeutics Inc
Name
Phone
(800) 466-6059
Name
Address
ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO
Name
Employee
70
Name
Twitter
Name
Next Earnings Date
2024-11-06
Name
Latest SEC Filings
Name
ALGS's Discussions on Twitter

Compare ALGS with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ALGS
Aligos Therapeutics Inc
7.65 52.34M 7.97M -75.74M -85.33M -24.29
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
429.95 109.22B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
635.53 67.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
428.34 57.35B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
841.11 50.87B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
185.50 39.72B 447.02M -1.18B -868.57M -6.1812

Aligos Therapeutics Inc Stock (ALGS) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-18-25 Resumed H.C. Wainwright Buy
Aug-19-24 Initiated H.C. Wainwright Buy
Jan-06-23 Upgrade Jefferies Hold → Buy
Jan-06-23 Upgrade Piper Sandler Neutral → Overweight
Mar-23-22 Downgrade Piper Sandler Overweight → Neutral
Jan-07-22 Downgrade JP Morgan Overweight → Neutral
Jan-06-22 Downgrade Jefferies Buy → Hold
Sep-09-21 Initiated SVB Leerink Outperform
May-17-21 Resumed Piper Sandler Overweight
Nov-10-20 Initiated Cantor Fitzgerald Overweight
Nov-10-20 Initiated JP Morgan Overweight
Nov-10-20 Initiated Jefferies Buy
Nov-10-20 Initiated Piper Sandler Overweight
View All

Aligos Therapeutics Inc Stock (ALGS) Latest News

pulisher
09:44 AM

Aligos Therapeutics Inc expected to post a loss of $1.90 a shareEarnings Preview - TradingView

09:44 AM
pulisher
08:51 AM

Aligos Therapeutics to Present at Upcoming Investor Conferences - The Manila Times

08:51 AM
pulisher
08:30 AM

Aligos Therapeutics (Nasdaq: ALGS) to present at Jefferies Nov 17 and Piper Sandler Dec 3 - Stock Titan

08:30 AM
pulisher
03:56 AM

How to forecast Aligos Therapeutics Inc. trends using time series2025 Earnings Surprises & Trade Opportunity Analysis Reports - newser.com

03:56 AM
pulisher
03:54 AM

When is the best time to exit Aligos Therapeutics Inc.CPI Data & Weekly Breakout Stock Alerts - newser.com

03:54 AM
pulisher
01:46 AM

Why Aligos Therapeutics Inc. stock remains on buy listsWeekly Profit Report & Community Driven Trade Alerts - newser.com

01:46 AM
pulisher
Nov 03, 2025

Will Aligos Therapeutics Inc. benefit from macro trendsJuly 2025 Fed Impact & Advanced Technical Signal Analysis - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Aligos Therapeutics Inc. (5WK0) stock resilient in recession scenarios2025 Performance Recap & Comprehensive Market Scan Insights - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Aligos Therapeutics Inc. (5WK0) stock safe for risk averse investors2025 Big Picture & Real-Time Price Movement Reports - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How to build a dashboard for Aligos Therapeutics Inc. stock2025 Market Outlook & Fast Exit and Entry Strategy Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How buybacks impact Aligos Therapeutics Inc. stock valueWeekly Stock Summary & High Conviction Buy Zone Picks - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How Aligos Therapeutics Inc. (5WK0) stock stacks up against competitors2025 Market WrapUp & Accurate Buy Signal Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Can Aligos Therapeutics Inc. (5WK0) stock double in coming years2025 Price Action Summary & Reliable Price Breakout Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Multi factor analysis applied to Aligos Therapeutics Inc.Dollar Strength & Safe Investment Capital Preservation Plans - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Is Aligos Therapeutics Inc a good long term investmentChart Pattern Recognition & Free Rapid Return Acceleration - earlytimes.in

Nov 02, 2025
pulisher
Nov 01, 2025

Is Aligos Therapeutics Inc. stock positioned well for digital economy2025 Major Catalysts & Free Growth Oriented Trading Recommendations - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Aligos Therapeutics, Inc. (ALGS) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK

Oct 31, 2025
pulisher
Oct 31, 2025

Is Aligos Therapeutics Inc. stock supported by strong fundamentalsEarnings Overview Report & Precise Buy Zone Tips - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Published on: 2025-10-31 04:14:04 - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Is Aligos Therapeutics Inc. (5WK0) stock a fit for income portfoliosDollar Strength & Weekly Stock Performance Updates - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Aligos Therapeutics to Announce 3rd Quarter 2025 Financial Results on November 6, 2025 - The Manila Times

Oct 30, 2025
pulisher
Oct 30, 2025

Aligos Therapeutics (Nasdaq: ALGS) to announce financial results Nov 6, 2025 - Stock Titan

Oct 30, 2025

Aligos Therapeutics Inc Stock (ALGS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$37.94
price up icon 1.81%
$29.21
price up icon 1.78%
$103.17
price up icon 1.52%
$104.28
price up icon 0.19%
biotechnology ONC
$315.21
price up icon 1.07%
$185.37
price down icon 0.56%
Cap:     |  Volume (24h):